Testicular degeneration in Huntington disease

Neurobiology of Disease

Volumn 26, Issue 3, 2007, Pages 512-520

  Van Raamsdonk, Jeremy M ^a   Murphy, Zoe ^a   Selva, David M ^a   Hamidizadeh, Reza ^b   Pearson, Jacqueline ^a   Petersén, Ǻsa ^c   Björkqvist, Maria ^c   Muir, Cameron ^d   Mackenzie, Ian R ^e   Hammond, Geoffrey L ^a   Vogl, A Wayne ^b   Hayden, Michael R ^a   Leavitt, Blair R ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c LUND UNIVERSITY   (Sweden)

^d BROCK UNIVERSITY   (Canada)

^e VANCOUVER GENERAL HOSPITAL   (Canada)

Author keywords

Huntingtin; Huntington disease; Hypothalamic pituitary gonadal axis; Testicular degeneration; Testis; Testosterone; YAC128 mouse model

Indexed keywords

GONADORELIN; HUNTINGTIN; TESTOSTERONE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN; CELL STRUCTURE; CONTROLLED STUDY; GENE MUTATION; GERM CELL; HUMAN; HUMAN CELL; HUNTINGTON CHOREA; HYPOTHALAMUS; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SEMINIFEROUS TUBULE; TESTIS DISEASE;

ADULT; AGED; ANIMALS; DISEASE MODELS, ANIMAL; GERM CELLS; GONADOTROPIN-RELEASING HORMONE; HUMANS; HUNTINGTON DISEASE; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; MALE; MICE; MICE, TRANSGENIC; MIDDLE AGED; NERVE TISSUE PROTEINS; NEURONS; NUCLEAR PROTEINS; SEMINIFEROUS TUBULES; TESTICULAR DISEASES; TESTIS; TESTOSTERONE;

EID: 34248531227     PISSN: 09699961     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nbd.2007.01.006     Document Type: Article

References (51)

1. Arrasate M., Mitra S., Schweitzer E.S., Segal M.R., and Finkbeiner S. Inclusion body formation reduces levels of mutant huntingtin and the risk of neuronal death. Nature 431 (2004) 805-810
2. Bird E.D., Chiappa S.A., and Fink G. Brain immunoreactive gonadotropin-releasing hormone in Huntington's chorea and in non-choreic subjects. Nature 260 (1976) 536-538
3. Bjorkqvist M., Fex M., Renstrom E., Wierup N., Petersen A., Gil J., Bacos K., Popovic N., Li J.Y., Sundler F., Brundin P., and Mulder H. The R6/2 transgenic mouse model of Huntington's disease develops diabetes due to deficient beta-cell mass and exocytosis. Hum. Mol. Genet. 14 (2005) 565-574
4. Bjorkqvist M., Petersen A., Bacos K., Isaacs J., Norlen P., Gil J., Popovic N., Sundler F., Bates G.P., Tabrizi S.J., Brundin P., and Mulder H. Progressive alterations in the hypothalamic-pituitary-adrenal axis in the R6/2 transgenic mouse model of Huntington's disease. Hum. Mol. Genet. 15 (2006) 1713-1721
5. Chan E.Y., Luthi-Carter R., Strand A., Solano S.M., Hanson S.A., DeJohn M.M., Kooperberg C., Chase K.O., DiFiglia M., Young A.B., Leavitt B.R., Cha J.H., Aronin N., Hayden M.R., and Olson J.M. Increased huntingtin protein length reduces the number of polyglutamine-induced gene expression changes in mouse models of Huntington's disease. Hum. Mol. Genet. 11 (2002) 1939-1951
6. Davies S.W., Turmaine M., Cozens B.A., Di Figlia M., Sharp A.H., Ross C.A., Scherzinger E., Wanker E.E., Mangiarini L., and Bates G.P. Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation. Cell 90 (1997) 537-548
7. Farrer L.A. Diabetes mellitus in Huntington disease. Clin. Genet. 27 (1985) 62-67
8. Fusco F.R., Chen Q., Lamoreaux W.J., Figueredo-Cardenas G., Jiao Y., Coffman J.A., Surmeier D.J., Honig M.G., Carlock L.R., and Reiner A. Cellular localization of huntingtin in striatal and cortical neurons in rats: lack of correlation with neuronal vulnerability in Huntington's disease. J. Neurosci. 19 (1999) 1189-1202
9. Gauthier L.R., Charrin B.C., Borrell-Pages M., Dompierre J.P., Rangone H., Cordelieres F.P., De Mey J., Macdonald M.E., Lessmann V., Humbert S., and Saudou F. Huntingtin controls neurotrophic support and survival of neurons by enhancing BDNF vesicular transport along microtubules. Cell 118 (2004) 127-138
10. Gunawardena S., Her L.S., Brusch R.G., Laymon R.A., Niesman I.R., Gordesky-Gold B., Sintasath L., Bonini N.M., and Goldstein L.S. Disruption of axonal transport by loss of huntingtin or expression of pathogenic polyQ proteins in Drosophila. Neuron 40 (2003) 25-40
11. Guo J., Zhu P., Wu C., Yu L., Zhao S., and Gu X. In silico analysis indicates a similar gene expression pattern between human brain and testis. Cytogenet. Genome Res. 103 (2003) 58-62
12. Gutekunst C.A., Li S.H., Yi H., Mulroy J.S., Kuemmerle S., Jones R., Rye D., Ferrante R.J., Hersch S.M., and Li X.J. Nuclear and neuropil aggregates in Huntington's disease: relationship to neuropathology. J. Neurosci. 19 (1999) 2522-2534
13. Guttman J.A., Kimel G.H., and Vogl A.W. Dynein and plus-end microtubule-dependent motors are associated with specialized Sertoli cell junction plaques (ectoplasmic specializations). J. Cell Sci. 113 Pt 12 (2000) 2167-2176
14. Hall E.S., Eveleth J., Jiang C., Redenbach D.M., and Boekelheide K. Distribution of the microtubule-dependent motors cytoplasmic dynein and kinesin in rat testis. Biol. Reprod. 46 (1992) 817-828
15. Harper, P., 1996. Huntington's disease, 2.
16. Hayden, M.R., 1981. Huntington's chorea.
17. Hurlbert M.S., Zhou W., Wasmeier C., Kaddis F.G., Hutton J.C., and Freed C.R. Mice transgenic for an expanded CAG repeat in the Huntington's disease gene develop diabetes. Diabetes 48 (1999) 649-651
18. Kremer H.P., Roos R.A., Dingjan G., Marani E., and Bots G.T. Atrophy of the hypothalamic lateral tuberal nucleus in Huntington's disease. J. Neuropathol. Exp. Neurol. 49 (1990) 371-382
19. Kremer H.P., Roos R.A., Dingjan G.M., Bots G.T., Bruyn G.W., and Hofman M.A. The hypothalamic lateral tuberal nucleus and the characteristics of neuronal loss in Huntington's disease. Neurosci. Lett. 132 (1991) 101-104
20. Lavin P.J., Bone I., and Sheridan P. Studies of hypothalamic function in Huntington's chorea. J. Neurol. Neurosurg. Psychiatry 44 (1981) 414-418
21. Leavitt B.R., Guttman J.A., Hodgson J.G., Kimel G.H., Singaraja R., Vogl A.W., and Hayden M.R. Wild-type huntingtin reduces the cellular toxicity of mutant huntingtin in vivo. Am. J. Hum. Genet. 68 (2001) 313-324
22. Luthi-Carter R., Hanson S.A., Strand A.D., Bergstrom D.A., Chun W., Peters N.L., Woods A.M., Chan E.Y., Kooperberg C., Krainc D., Young A.B., Tapscott S.J., and Olson J.M. Dysregulation of gene expression in the R6/2 model of polyglutamine disease: parallel changes in muscle and brain. Hum. Mol. Genet. 11 (2002) 1911-1926
23. Macdonald M.E., Ambrose C.M., Duyao M.P., Myers R.H., Lin C., Srinidhi L., Barnes G., Taylor S.A., James M., Groot N., Macfarlane H., Jenkins B., Anderson M.A., Wexler N.S., Gusella J.F., Bates G.P., Baxendale S., Hummerich H., Kirby S., North M., Youngman S., Mott R., Zehetner G., Sedlacek Z., Poustka A., Frischauf A.M., Lehrach H., Buckler A.J., Church D., Doucettestamm L., Odonovan M.C., Ribaramirez L., Shah M., Stanton V.P., Strobel S.A., Draths K.M., Wales J.L., Dervan P., Housman D.E., Altherr M., Shiang R., Thompson L., Fielder T., Wasmuth J.J., Tagle D., Valdes J., Elmer L., Allard M., Castilla L., Swaroop M., Blanchard K., Collins F.S., Snell R., Holloway T., Gillespie K., Datson N., Shaw D., and Harper P.S. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntingtons-disease chromosomes. Cell 72 (1993) 971-983
24. Mangiarini L., Sathasivam K., Seller M., Cozens B., Harper A., Hetherington C., Lawton M., Trottier Y., Lehrach H., Davies S.W., and Bates G.P. Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice. Cell 87 (1996) 493-506
25. Markianos M., Panas M., Kalfakis N., and Vassilopoulos D. Plasma testosterone in male patients with Huntington's disease: relations to severity of illness and dementia. Ann. Neurol. 57 (2005) 520-525
26. Mastromauro C.A., Meissen G.J., Cupples L.A., Kiely D.K., Berkman B., and Myers R.H. Estimation of fertility and fitness in Huntington disease in New England. Am. J. Med. Genet. 33 (1989) 248-254
27. Miller M.G., Mulholland D.J., and Vogl A.W. Rat testis motor proteins associated with spermatid translocation (dynein) and spermatid flagella (kinesin-II). Biol. Reprod. 60 (1999) 1047-1056
28. Muir C., Spironello-Vella E., Pisani N., and deCatanzaro D. Enzyme immunoassay of 17 beta-estradiol, estrone conjugates, and testosterone in urinary and fecal samples from male and female mice. Horm. Metab Res. 33 (2001) 653-658
29. Papalexi E., Persson A., Bjorkqvist M., Petersen A., Woodman B., Bates G.P., Sundler F., Mulder H., Brundin P., and Popovic N. Reduction of GnRH and infertility in the R6/2 mouse model of Huntington's disease. Eur. J. Neurosci. 22 (2005) 1541-1546
30. Petersen A., Gil J., Maat-Schieman M.L., Bjorkqvist M., Tanila H., Araujo I.M., Smith R., Popovic N., Wierup N., Norlen P., Li J.Y., Roos R.A., Sundler F., Mulder H., and Brundin P. Orexin loss in Huntington's disease. Hum. Mol. Genet. 14 (2005) 39-47
31. Podolsky S., Leopold N.A., and Sax D.S. Increased frequency of diabetes mellitus in patients with Huntington's chorea. Lancet 1 (1972) 1356-1358
32. Pridmore S.A., and Adams G.C. The fertility of HD-affected individuals in Tasmania. Aust. N. Z. J. Psychiatry 25 (1991) 262-264
33. Ribchester R.R., Thomson D., Wood N.I., Hinks T., Gillingwater T.H., Wishart T.M., Court F.A., and Morton A.J. Progressive abnormalities in skeletal muscle and neuromuscular junctions of transgenic mice expressing the Huntington's disease mutation. Eur. J. Neurosci. 20 (2004) 3092-3114
34. Russell L.D., Malone J.P., and MacCurdy D.S. Effect of the microtubule disrupting agents, colchicine and vinblastine, on seminiferous tubule structure in the rat. Tissue Cell 13 (1981) 349-367
35. Sathasivam K., Hobbs C., Turmaine M., Mangiarini L., Mahal A., Bertaux F., Wanker E.E., Doherty P., Davies S.W., and Bates G.P. Formation of polyglutamine inclusions in non-CNS tissue. Hum. Mol. Genet. 8 (1999) 813-822
36. Selva D.M., Tirado O.M., Toran N., Suarez-Quian C.A., Reventos J., and Munell F. Meiotic arrest and germ cell apoptosis in androgen-binding protein transgenic mice. Endocrinology 141 (2000) 1168-1177
37. Selva D.M., Hirsch-Reinshagen V., Burgess B., Zhou S., Chan J., McIsaac S., Hayden M.R., Hammond G.L., Vogl A.W., and Wellington C.L. The ATP-binding cassette transporter 1 mediates lipid efflux from Sertoli cells and influences male fertility. J. Lipid Res. 45 (2004) 1040-1050
38. Shokeir M.H. Investigation on Huntington's disease in the Canadian Prairies II. Fecundity and fitness. Clin. Genet. 7 (1975) 349-353
39. Slow E.J., van Raamsdonk J., Rogers D., Coleman S.H., Graham R.K., Deng Y., Oh R., Bissada N., Hossain S.M., Yang Y.Z., Li X.J., Simpson E.M., Gutekunst C.A., Leavitt B.R., and Hayden M.R. Selective striatal neuronal loss in a YAC128 mouse model of Huntington disease. Hum. Mol. Genet. 12 (2003) 1555-1567
40. Slow E.J., Graham R.K., Osmand A.P., Devon R.S., Lu G., Deng Y., Pearson J., Vaid K., Bissada N., Wetzel R., Leavitt B.R., and Hayden M.R. Absence of behavioral abnormalities and neurodegeneration in vivo despite widespread neuronal huntingtin inclusions. Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 11402-11407
41. Strand A.D., Aragaki A.K., Shaw D., Bird T., Holton J., Turner C., Tapscott S.J., Tabrizi S.J., Schapira A.H., Kooperberg C., and Olson J.M. Gene expression in Huntington's disease skeletal muscle: a potential biomarker. Hum. Mol. Genet. 14 (2005) 1863-1876
42. Sugars K.L., and Rubinsztein D.C. Transcriptional abnormalities in Huntington disease. Trends Genet. 19 (2003) 233-238
43. Szebenyi G., Morfini G.A., Babcock A., Gould M., Selkoe K., Stenoien D.L., Young M., Faber P.W., Macdonald M.E., McPhaul M.J., and Brady S.T. Neuropathogenic forms of huntingtin and androgen receptor inhibit fast axonal transport. Neuron 40 (2003) 41-52
44. Trushina E., Dyer R.B., Badger J.D., Ure D., Eide L., Tran D.D., Vrieze B.T., Legendre-Guillemin V., McPherson P.S., Mandavilli B.S., Van Houten B., Zeitlin S., McNiven M., Aebersold R., Hayden M., Parisi J.E., Seeberg E., Dragatsis I., Doyle K., Bender A., Chacko C., and McMurray C.T. Mutant huntingtin impairs axonal trafficking in mammalian neurons in vivo and in vitro. Mol. Cell. Biol. 24 (2004) 8195-8209
45. Van Raamsdonk J.M., Murphy Z., Slow E.J., Leavitt B.R., and Hayden M.R. Selective degeneration and nuclear localization of mutant huntingtin in the YAC128 mouse model of Huntington disease. Hum. Mol. Genet. 14 (2005) 3823-3835
46. Van Raamsdonk J.M., Pearson J., Rogers D.A., Bissada N., Vogl A.W., Hayden M.R., and Leavitt B.R. Loss of wild-type huntingtin influences motor dysfunction and survival in the YAC128 mouse model of Huntington disease. Hum. Mol. Genet. 14 (2005) 1379-1392
47. Van Raamsdonk J.M., Pearson J., Slow E.J., Hossain S.M., Leavitt B.R., and Hayden M.R. Cognitive dysfunction precedes neuropathology and motor abnormalities in the YAC128 mouse model of Huntington's disease. J. Neurosci. 25 (2005) 4169-4180
48. Van Raamsdonk J.M., Gibson W.T., Pearson J., Murphy Z., Lu G., Leavitt B.R., and Hayden M.R. Body weight is modulated by levels of full-length Huntingtin. Hum. Mol. Genet. 15 (2006) 1513-1523
49. Vogl A.W., Linck R.W., and Dym M. Colchicine-induced changes in the cytoskeleton of the golden-mantled ground squirrel (Spermophilus lateralis) Sertoli cells. Am. J. Anat. 168 (1983) 99-108
50. Vonsattel J.P., and DiFiglia M. Huntington disease. J. Neuropathol. Exp.Neurol. 57 (1998) 369-384
51. Weiss M., Vigier M., Hue D., Perrard-Sapori M.H., Marret C., Avallet O., and Durand P. Pre- and postmeiotic expression of male germ cell-specific genes throughout 2-week cocultures of rat germinal and Sertoli cells. Biol. Reprod. 57 (1997) 68-76